JGAVX
Price
$87.57
Change
+$0.19 (+0.22%)
Updated
Jul 14 closing price
Net Assets
6.47B
RMEBX
Price
$59.87
Change
+$0.15 (+0.25%)
Updated
Jul 14 closing price
Net Assets
108.87B
Interact to see
Advertisement

JGAVX vs RMEBX

Header iconJGAVX vs RMEBX Comparison
Open Charts JGAVX vs RMEBXBanner chart's image
JPMorgan US Value R3
Price$87.57
Change+$0.19 (+0.22%)
VolumeN/A
Net Assets6.47B
American Funds American Mutual R2E
Price$59.87
Change+$0.15 (+0.25%)
VolumeN/A
Net Assets108.87B
JGAVX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JGAVX vs. RMEBX commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGAVX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 109B vs. JGAVX (6.47B). RMEBX (1.12) and JGAVX (1.07) have matching dividends . JGAVX was incepted earlier than RMEBX: JGAVX (8 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than JGAVX (1.01). RMEBX is a more actively managed with annual turnover of: 31.00 vs. JGAVX (18.00). JGAVX has a lower initial minimum investment than RMEBX: JGAVX (0) vs RMEBX (250). RMEBX (9.49) and JGAVX (9.17) have marching annual gain over last year. JGAVX return over 5 years is better than : 83.56 vs. RMEBX (57.31).
JGAVXRMEBXJGAVX / RMEBX
Total Expense Ratio0.941.0788%
Annual Report Gross Expense Ratio1.011.0794%
Fund Existence8 years11 years-
Gain YTD6.5959.64168%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.47B109B6%
Annual Yield % from dividends1.071.1296%
Returns for 1 year9.179.4997%
Returns for 3 years40.5030.38133%
Returns for 5 years83.5657.31146%
Returns for 10 yearsN/A74.78-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNPCX67.640.13
+0.19%
American Funds New Perspective R3
FLDGX14.39N/A
N/A
Meeder Dynamic Allocation Retail
ETAHX33.53N/A
N/A
Eventide Healthcare & Life Sciences A
BEXIX17.53N/A
N/A
Baron Emerging Markets Institutional
JHSMX12.19N/A
N/A
JHancock International Small Company R6